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Abstract
The structures of functional peptides corresponding to the predicted channel-lining M2 segment of the nicotinic acetylcholine (AChR)
were determined using solution NMR experiments on micelle samples, and solid-state NMR experiments on bilayer samples. The AChR
M2 peptide forms a straight transmembrane a-helix, with no kinks. M2 inserts in the lipid bilayer at an angle of 12j relative to the
bilayer normal, with a rotation about the helix long axis such that the polar residues face the N-terminus of the peptide, which is
assigned to be intracellular. A molecular model of the AChR channel pore, constructed from the solid-state NMR 3-D structure of the
AChR M2 helix in the membrane assuming a pentameric organization, results in a funnel-like architecture for the channel with the wide
opening on the N-terminal intracellular side. A central narrow pore has a diameter ranging from about 3.0 A˚ at its narrowest, to 8.6 A˚
at its widest. Nonpolar residues are predominantly on the exterior of the bundle, while polar residues line the pore. This arrangement is
in fair agreement with evidence collected from permeation, mutagenesis, affinity labeling and cysteine accessibility measurements. A
pentameric M2 helical bundle may, therefore, represent the structural blueprint for the inner bundle that lines the channel of the nicotinic
AChR.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Perspectives and overview
Neurons communicate with each other by means of
neurotransmitters [1]. The vast and intricate connectivity
of the human brain combined with the diversity of neuro-
transmitters is at the root of the combinatorial power that
contributes to the dynamic complexity of the brain. Synaptic
communication is tightly regulated and, accordingly, alter-
ations lead to dysfunction, which range from developmental
abnormalities to aberrant behavior. Ostensibly, the proteins
involved in the process are membrane proteins or membrane
associated proteins and still little is known about their
molecular structure, dynamics and interactions. Our
research is focused on channel proteins, which are pivotal
components of this fascinating system, and the models
currently in vogue to understand how their structure pro-
duces their function or dysfunction.
The expectation that well in excess of 1000 new potential
drugs in the field of neuroscience will be derived from
genomics and that >90% of these will be targeted to
channels and receptors will require structural knowledge
of the drug binding pocket. This fertile field provides an
unparalleled opportunity to blend the power of structural
biology and membrane biophysics in order to define the
folds adopted by channel proteins to fulfill their function
and to facilitate drug design targeted to block or modulate
channel activity arising from dysfunctional channels.
The thrust of our research aims to establish structure–
function relationships in channel proteins with a primary
emphasis on the transmembrane domain. Even today, there
is only a handful of high-resolution structures of channel
proteins, a major gap in our knowledge about this class of
proteins that are critical for signaling in cells. These struc-
tures, excluding the bacterial porins, are for KcsA-a K+
channel of S. lividans [2], MscL—a mechanosensitive
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channel of Mycobacterium tuberculosis [3], GlpF—a glyc-
erol-conducting channel from Escherichia coli [4], the
AQP1 water channel [5], and two bacterial chloride chan-
nels from the CLC family [6], all determined by X-ray
crystallography. We have applied solid-state NMR methods
to elucidate the structures of several channel proteins. A
unique advantage of solid-state NMR methods is that
protein structure is determined in the lipid bilayer, which
is the biologically relevant environment for membrane
proteins. NMR spectroscopy is ideally suited to probe
protein dynamics, a feature of utmost importance in systems
such as channel proteins where conformational transitions
are at the core of their biological action.
Our initial studies have been an integral part of the
development of the NMR approach to structure determina-
tion of membrane proteins, and they have been focused on
functional 25-residue peptides corresponding to the pore
forming elements of acetylcholine receptors (AChR), gly-
cine receptors (GlyR), and glutamate receptors (GluR).
These functional peptides have enabled us to formalize a
hierarchical approach to structure. However, our ultimate
goal is to build upon these results to study intact functional
ion-channels. Although multidimensional solution NMR
methods can be successfully applied to relatively small
membrane proteins in micelles in favorable cases [7], the
size limitation is more severe than for globular proteins
because the lipid molecules associated with each polypep-
tide slow the overall reorientation rate. Moreover, it is
highly desirable to determine the structures of membrane
proteins in the definitive environment of phospholipid
bilayers where solution NMR methods fail completely.
Recently, we determined the 3-D structure of a 25-residue
M2 channel forming peptide from AChRs by solid-state
NMR spectroscopy [8]. We turn now to summarize the key
features of this endeavor.
2. The nicotinic acetylcholine receptor channel
Our focus has been on neurotransmitter-gated ion chan-
nels, a superfamily of oligomeric proteins in the postsynap-
tic membrane of neurons which are responsible for neuronal
communication [1,9], and specifically on the channel-form-
ing domain confined to the membrane. The nicotinic AChR
has been one of the most extensively studied members of a
growing superfamily of ligand-gated channels [10,11]. It is
a pentamer of homologous subunits organized around a
central aqueous pore. The ligand-binding domain is exposed
to the extracellular surface and is largely formed by the N-
terminal region of the a subunits. Two agonist binding sites
are formed at the interface between the two a subunits and
the adjacent subunit-a and g, and a and y subunits for the
muscle AChR, or between adjacents a subunits for the
homopentameric a7 neuronal AChR.
The recent crystal structure of a snail ACh-binding
protein (AChBP) [12] that is secreted from the molluscan
glial cells and has sequence similarities to the N-terminal
domain of the nicotinic AChR has revealed the essential
features of this extramembranous domain, supporting a
modular design. Remarkably, the structure of the AChBP
homopentamer solved at 2.7 A˚ resolution compares favor-
ably with the corresponding domain in the 4.6 A˚ structure of
the Torpedo marmorata AChR determined by cryo-EM
combined with image reconstruction [13]. It also accounts
for a plethora of biochemical, mutagenesis and electro-
physiological information. Each protomer in the pentamer
adopts a modified immunoglobin fold with a core of 10
twisted h strands that generate two separate hydrophobic
cores. The pentamer has a central hydrophilic pore of f 20
A˚ in diameter, lined with charged residues. There is a cavity
at each interface between the five subunits lined by hydro-
phobic residues and formed by four loops (A–D), which
were previously identified in biochemical experiments as
constituents of the AChR ACh binding site [14]. The bind-
ing pocket for ACh in AChBP is created by five aromatic
residues: a Tyr on loop A, a conspicuous Trp on loop B, two
Tyr separated by seven residues on loop C, and a Trp on
loop D. It is not clear how the ligand binding event in this
surface exposed module is transmitted to the channel form-
ing domain embedded within the membrane bilayer to
trigger channel opening. However, the structure of the
AChBP suggests that such a ligand-binding module is well
suited to interact specifically with the pore module and it
provides a structural framework to pursue an understanding
of the elusive coupling between ligand binding and channel
opening.
What, then, do we know about the AChR transmembrane
domain? A canonical structure suggests the occurrence in
each subunit of four potential TMs, M1–M4. The mem-
brane domain has high sequence similarity among members
of this gene superfamily which encompasses receptors for
the major inhibitory neurotransmitters glycine and GABA
(g-amino butyric acid). In particular, the high conservation
of the M2 sequence and its amphipathic character suggested
its dominant contribution to the structure that actually lines
the channel. This assignment is compatible with a large
body of evidence derived primarily from mutagenesis and
affinity-labeling experiments [10,11,15–20]. The 9 A˚ struc-
ture of the T. marmorata AChR determined by Unwin
[21,22] using cryo-EM combined with image reconstruction
indicated the presence of only one rod of density compatible
with a single transmembrane helix in each receptor subunit.
The inner bundle that lines the pore was postulated to be
formed by M2 helices whereas the outer rim of three-
stranded antiparallel h-sheets may be contributed by M1,
M3, and/or M4. The 4.6 A˚ structure [13] has not unequiv-
ocally identified the secondary structure of M1, M3, and
M4. Evidence derived from CD [23] and infrared spectra of
transmembrane domain preparations is consistent with the
occurrence of four transmembrane helices in each subunit
[24]. This issue will likely be resolved when the much
anticipated higher resolution structure derived from Unwin’s
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[21] recent technical refinements and additional averaging
becomes available in the near future.
3. M2 structural studies
Focusing on M2, both the 9 and 4.6 A˚ electron dif-
fraction maps suggest a model in which the channel pore
is formed by a bundle of five M2 a-helices, each
contributed by one subunit of the AChR pentamer
[13,21,22]. This model is compatible with conformational
energy calculations refined using molecular dynamics
[25–27], mutagenesis and substituted cysteine accessibil-
ity data [10,11,15–20]. The total chemical synthesis of a
five-helix bundle protein designed to imitate this motif
has been achieved [28,29]. The designed protein approx-
imates some of the permeation properties of the authentic
T. californica AChR reconstituted in lipid bilayers, includ-
ing single channel conductance, cation selectivity and
channel blockade. From a minimalist viewpoint, it seems
that this fold would support the fundamental function of
the AChR channel. Is it possible to determine the 3-D
structure of the M2 channel-lining segment in a mem-
brane?
This has been achieved: It is the first high-resolution
structure of a functional module derived from a eukaryotic
channel protein in a membrane. The 3-D structure of a
functional peptide corresponding to the M2 segment from
the y-subunit of the AChR was determined by solution and
solid-state NMR spectroscopy in membrane environments
[8,30]. These studies exemplify an essential feature of our
approach, which is the direct correlation of the structures
obtained by NMR spectroscopy in micelles and bilayers
with the functional properties of the channels recorded after
reconstitution of the same polypeptides into bilayers. Iso-
topically labeled M2 peptides required for NMR spectro-
scopy were prepared by expression of recombinant peptides
in E. coli, for selective or uniform isotopic labeling, or by
solid-phase synthesis, for specific residue labeling of the
samples.
The AChR M2 peptide forms cation-selective channels
in lipid bilayers (Fig. 1a). The channels display heteroge-
neous conductances and lifetimes, as expected for mono-
meric peptides that self-assemble into conductive oligomers
of discrete yet variable size. The channels that occur most
frequently exhibit a single-channel conductance (c) of 37F 2
pS in 0.5 M NaCl. The currents of closed (C) and open (O)
states are indicated by the solid lines. Dotted lines define the
range set to discriminate the transitions between states, based
on signal-to-noise measurements. Conductances were cal-
culated from the corresponding Gaussian fits to current
histograms; the respective probabilities (P) of the open (O)
versus closed (C) channel states are indicated (Fig. 1b). The
results indicate that both the recombinant and synthetic
AChR M2 peptides used in the NMR experiments are func-
tional, and form sequence-specific, discrete ion-channels
in lipid bilayers [8]. To the extent that the peptides mimic
the predicted channel lining sequence (EKMSTAISVLLA-
QAVFLLLTSQR), their permeation properties compare
favorably with those of the intact homomeric AChR.
The 2-D solution 1H/15N HMQC (heteronuclear multi-
ple quantum correlation) NMR spectrum of uniformly 15N-
labeled AChR M2 peptide in dodecylphosphocholine
(DPC) micelles is well resolved, with each amide reso-
nance characterized by isotropic 1H and 15N chemical shift
frequencies (Fig. 2a). The 2-D solid-state PISEMA [8,30]
(polarization inversion spin exchange at the magic angle)
spectrum of the same peptide in oriented bilayers (Fig. 2b)
is well resolved, with each amide resonance characterized
by 15N chemical shift and 1H–15N dipolar coupling fre-
quencies. The parallel development of solution NMR spec-
troscopy of lipid micelle samples and solid-state NMR
spectroscopy of oriented lipid bilayer samples to yield
high-quality spectra with similar resolution is of paramount
significance. The primary constraint used for structure
determination by solution NMR spectroscopy is the ho-
monuclear 1H/1H NOE. The 10 lowest energy structures
that satisfy the NMR data, with no NOE violations greater
than 0.5 A˚ and no dihedral angle violations greater than
5j, and maintain acceptable peptide geometry, are shown
Fig. 1. (a) Single channel recordings from recombinant AChR M2 peptides
in lipid bilayers. The currents were recorded at 50 mV in symmetric 0.5 M
NaCl supplemented with 1 mM CaCl2, 5 mM Hepes pH 7.4. The currents
of closed (C) and open (O) states are indicated by the solid lines. The single
channel conductance was 37F 2 pS. (b) Corresponding current histogram.
The Gaussian fit of the data indicates the respective probabilities of the
open (O) versus closed (C) channel states.
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in Fig. 3a. The structures overlay best from residues Lys-2
to Gln-22 where the average RMSD of the heavy atoms of
the backbone from the average structure is 0.77F 0.2 A˚.
The results show that the AChR M2 peptide adopts an a-
helical structure in DPC micelles, which is only slightly
curved and show no evidence of kinks.
Solid-state NMR spectroscopy on oriented lipid bilayer
samples is unique in determining the complete topology,
including 3-D structure and global orientation, of the pep-
tide in the membrane, at high resolution [31,32]. The
orientationally dependent 15N chemical shift and 1H–15N
dipolar coupling frequencies provide orientational con-
straints for structure determination of 15N labeled peptides
in lipid bilayer membranes, and can be measured directly
from the 2-D PISEMA spectrum of the AChR M2 peptide
(Fig. 2b). In this spectrum, the presence of a single reso-
nance for each individual residue implies that the AChR M2
peptides adopt a single conformation in the lipid bilayer.
Most of the resonances in Fig. 2b were assigned to specific
residues through comparisons with spectra from selectively
15N-labeled recombinant peptides, and specifically 15N-
labeled synthetic peptides. Some resonances were assigned
with 15N dilute spin-exchange experiments. The backbone
structure of AChR M2, determined from 15N chemical shift,
1H–15N dipolar coupling, and some 1H chemical shift
constraints, is shown in Fig. 3b. Superposition of the
solution (black) and solid-state (cyan) NMR structures
shows that they are similar, with an RMSD of 0.6 A˚ for
the backbone atoms.
Using the solid-state NMR orientational constraints, we
determined that the AChR M2 peptide is a transmembrane,
amphipathic a-helix with its long helix axis tilted 12j from
the lipid bilayer normal [8], in agreement with the structure
inferred from the 9 and 4.6 A˚ electron diffraction maps
[13,21,22]. The peptide is rotated around its helix long axis
such that the polar residues face the N-terminus of the
peptide, which is assigned to be intracellular [8,10,11]. In
solid-state NMR of oriented lipid bilayer samples, 3-D
structural coordinates are determined directly from the
NMR data relative to an external reference, namely the
lipid bilayer normal, which is set parallel to the magnetic
field by the method of sample preparation. As a result, the 3-
D structure of the M2 peptide is fixed within the lipid
bilayer, and inherently contains the helix tilt and helix
rotation information. This implies that the solid-state
NMR structure must be viewed as a supramolecular assem-
bly, together with the bilayer membrane.
A molecular model of the AChR channel pore, con-
structed from the solid-state NMR 3-D structure of the
AChR M2 helix in the membrane, and assuming a sym-
metric pentameric organization of the channel is shown in
Fig. 4a (end view) and Fig. 4b (side view). The optimized
parallel, five-helix bundle has a right handed, interhelical
twist with an orientation angle of 12j. A Na+ is confined
in the central narrow pore, which has a diameter ranging
from about 3.0 A˚ at its narrowest, to 8.6 A˚ at its widest
(Fig. 4a). Nonpolar residues are predominantly on the
exterior of the bundle, while polar residues line the pore.
This arrangement is in agreement with evidence collected
from mutagenesis, affinity labeling and cysteine accessi-
bility measurements [8,10,11,15–20]. Specifically, cysteine
scanning [18] identified eight residues accessible to mod-
ification by methane thiosulfonate reagents in M2 of the
AChR a subunit in the open channel: Glu-1, Thr-4, Ser-8,
Leu-11, Ser-12, Val-15, Leu-18, and Glu-22. Five of these
residues are exposed to the pore lumen in the structure
shown in Fig. 4a: Glu-1, Ser-4, Ser-8, Val-15, Leu-18, and
Gln-22. A side view (Fig. 4b) shows a funnel-shaped
Fig. 2. (a) Solution 1H chemical shift/15N chemical shift correlation HMQC
NMR spectrum of AChR M2 in DPC micelles, at 20 jC. Four transients
were acquired for each of 256 t1 increments. (b) Solid-state
1H–15N
dipolar/15N chemical shift correlation PISEMA NMR spectrum of AChR
M2 in oriented DMPC bilayers, at 22 jC. Two hundred and fifty-six
transients were acquired for each of 64 t1 values incremented by 40.8 As.
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bundle, 33 A˚ in length, with the wide mouth at the N-
terminus, which is assigned to be intracellular in keeping
with the wealth of biochemical and mutagenesis informa-
tion [8]. The profile of the ion-conduction pore calculated
from the structure shows a wide infundibulum leading to
two narrow constrictions generated by rings of Val-15 and
Gln-22, with hole radii of 2.9 and 1.5 A˚, respectively [8].
The channel lining hydroxyl residues are in agreement
with the expectations of a water-filled pore, and the
constrictions are compatible with the permeation of both
Na+ and K+ ions (ionic radii of 0.95 and 1.33 A˚,
respectively). Remarkably, replacement of Glu-1 by Ala,
Val-15 by Thr, and insertion of a proline immediately
preceding Glu-1 in homomeric neuronal a7 AChRs con-
verts the channel ionic selectivity from cationic to anionic
[15,16]. The wide cavity delimited between Ser-8 and Val-
15 is consistent with the binding pocket for open channel
blockers [20]. Therefore, a pentameric M2 helical bundle
may represent the structural blueprint for the inner bundle
that lines the pore of the AChR channel. Indeed, the 4.6 A˚
electron diffraction map of the closed AChR channel
shows the occurrence of two rings of conserved hydro-
phobic residues generating a belt around the pore: one ring
formed by Leu-11 and the other by Val-15, separated by
one turn of helix. Unwin [21,22] suggested that this may
represent the structure of a hydrophobic gate that would
hinder the dehydration of ions and render them too large to
pass through the central pore.
Overall, the structural features of the five-helix bundle
of the AChR M2 shown in Fig. 4a and b are similar to
those identified in the crystal structures of the tetrameric
pore of the K channel KcsA [2] and the pentameric pore
of the mechanosensitive channel MscL [3]. The ion-con-
ducting pathway is formed by helical bundles packed
around a central pore; the pores have a funnel-like archi-
tecture, with each subunit contributing two transmembrane
a-helical segments, tilted by f 25j with respect to the
bilayer normal; the helices pack together as right-handed
helical bundles. The pentameric pore of MscL [3] bears
striking resemblance to the pentameric AChR M2 bundle:
the N-terminal transmembrane helix of MscL (TM1) forms
the channel lining and exposes to the pore lumen a number
of hydroxyl-containing polar residues: Thr-25, Thr-28,
Thr-32, and Thr-35. Two hydrophobic residues (Ile-14
and Val-21), two turns of helix apart, create a constriction
near the cytoplasmic surface at the N-terminus of TM1.
Thus, the sequence and amphipathic character of the TM1
helix, orientation, packing, and tilt angle are ostensibly
similar to the AChR M2 helix. The occurrence of a pore
constriction formed by hydrophobic residues in the pre-
sumed closed channel is reminiscent of that in the AChR
M2 bundle and it may be critical for channel opening if
that were to involve a rotation of the M2 helices, thereby
repositioning the occluding hydrophobic residues to a
permissive location. Helix rotations and changes in tilt
angle have been implicated in the mechanism of channel
gating both for ligand-gated [21] and voltage-gated [33,34]
channels. For KcsA, a site-directed spin labeling and EPR
spectroscopy study has discerned such a motion in TM2
helix that displaces it away from the conducting pathway
and results in a widening of a pore at its narrowest
constriction [35].
The earlier finding that the M2 segments of the glycine
receptor (GlyR) family form anion-selective channels in
Fig. 3. (a) Superposition of the backbone heavy atoms for the 10 lowest energy structures of AChR M2 determined by solution NMR in DPC micelles. (b)
Superposition of the average structure of the AChR M2 calculated from the solution NMR distance constraints (black), and the average structure determined
from the solid-state NMR orientational constraints (cyan). Both structures are shown in the bilayer membrane, in the exact overall orientation determined from
solid-state NMR.
M. Montal, S.J. Opella / Biochimica et Biophysica Acta 1565 (2002) 287–293 291
lipid bilayers [36], and are transmembrane a-helices as
determined by NMR spectroscopy [37,38], supports the
structural kinship of AChR and GlyR. Remarkably, the
inverse three mutations that convert the homomeric neuro-
nal a7 AChRs from cation-selective to anion-selective (Ala-
1 by Glu, Thr-15 by Val, and insertion of a proline im-
mediately preceding Ala-1) [15], when introduced into M2
of the Cl conducting homomeric a1 GlyR converted it
from anion-selective to cation-selective [39]. It is therefore
plausible that a pentameric M2 helical bundle represents the
blueprint for the structure that lines the pore of Gly-gated
Cl channels.
What the structure of the M2 bundle is in the context of
the intact AChR subunit within the pentameric complex
remains to be established. In the meantime, this issue may
be assessed through the effects of mutations identified in
human diseases which alter the functional properties of the
mutant receptor. A case in point is nocturnal frontal lobe
epilepsy: Ser-8, a key residue exposed to the pore lumen is
mutated to Phe in the neuronal a4 AChR subunit; in oocyte
expression experiments, the mutated human a4 AChR
exhibits increased affinity for ACh and increased rate of
desensitization [40,41]. For M2 of the GlyR a1, a mutation
of Gln-15 (a position equivalent to that of the critical Val-15
in the AChR M2) for His is associated with hyperekplexia
(Startle disease) [42,43]. This is precisely what the pen-
tameric M2 helical bundle model would predict.
4. Concluding remarks
We have described a hierarchical strategy to elucidate
sequence-structure determinants by investigating autono-
mously folded modules in the absence of the entire channel
protein. This endeavor has led to the determination of the
structure of the channel lining segments of neurotransmitter-
gated channels in membranes. The advances reviewed set us
on a solid framework to proceed to the determination of the
structure of an intact channel protein embedded in mem-
branes by NMR spectroscopy.
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